Blog
Why These Two Dividend Stocks Look Like Compelling Buys
Yield-hunters are always looking for stocks that not only offer attractive yields, but also impressive growth prospects. The key is to have a regular, growing income stream while preserving capital
Spotify's Latest Buy: Another Big Bet on Podcasts' Future
Spotify (NYSE: SPOT), the global leader in music streaming, announced on Nov. 10 that it is acquiring podcast advertising and publishing platform Megaphone. The deal values Megaphone at $235 million
Is This Weight Loss Company Coming for WW And Noom's Market Share?
For many people, the coronavirus pandemic has changed their nutrition and exercise habits. One app helping people track their food and lose weight is called Lifesum. This private startup has scaled
What Potential Investors Need to Know About DoorDash
In this episode of Industry Focus: Consumer Goods, Emily Flippen and Motley Fool contributor Jason Hall take a deep dive into the S-1 filing of the largest food delivery platform in the U.S
The Vaccines Are Almost Ready, but the Challenges Are Only Beginning
The coronavirus pandemic is ushering in a wave of innovation across industries, and it's not just the vaccine makers who are trying new things. Now that Pfizer (NYSE: PFE) and BioNTech (NASDAQ:
Ask A Virologist: How Does GlaxoSmithKline's Potential Coronavirus Vaccine Work?
Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the
The 2 Top Stocks in Retail Apparel
The retail apparel industry was upended by the current pandemic. Stores deemed "non-essential" were forced to shutter and business suffered greatly as a result.
Still, there will be winners in the
Will Moderna's Coronavirus Vaccine Really Change the Game?
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.
Moderna's (NASDAQ: MRNA) CEO Stephane Bancel calls his company's vaccine candidate a "game changer." But he's not
These 3 Stocks Got Even Stronger During the COVID-19 Pandemic
There's seemingly no end to the discussion about which stocks will benefit from stay-at-home measures, and which stocks will benefit from a coronavirus vaccine. However, what about businesses that
Is Colgate Palmolive a Buy?
Colgate-Palmolive (NYSE: CL) is a familiar name to many investors. After all, you've probably passed many of its products in the grocery aisle, and likely put some of the items in your cart before
Why Do Baby Boomers Hate Tesla?
For the most part, young investors love the same stocks that older investors do. After all, gains are gains regardless of who produces them. That's why Apple and Amazon are key components in so many
Coronavirus Vaccines: A Game-Changer for Boeing Stock?
The first few months of 2020 were terrible for Boeing (NYSE: BA) shareholders. Boeing stock had already struggled in 2019 because of the 737 MAX grounding. The COVID-19 pandemic made the aerospace
173 Million Americans Want Marijuana Legalized -- Here's Why That's Not Happening
Earlier this month, we witnessed another step in the cannabis revolution. Marijuana legalization initiatives made the ballot in five states, and residents passed each measure with ease. This
5 Things to Know About Medicare Advantage Plans in 2021
More than 60 million people get health coverage through Medicare, about one-third of whom choose to get benefits through Medicare Advantage instead of original Medicare. Advantage plans are offered
Lowe's Upgrades Its Market Share Challenge Against Home Depot
Lowe's (NYSE: LOW) is still outgrowing the booming home improvement industry. The retailer last Wednesday announced third-quarter earnings results that closed the sales and profitability gap with
Could This One Deal Nearly Double Beyond Meat's Revenue?
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) went on a little roller coaster ride recently. The volatility was related to McDonald's (NYSE: MCD) new plant-based burger called the
Will the Work-From-Home Trend Continue After the Pandemic?
With millions of workers doing their jobs remotely, there has been a widespread belief that offices might become a thing of the past. In this Nov. 16 Fool Live video clip, certified financial
If You Invested $1,000 in Silicon Valley Bank's IPO, This Is How Much Money You'd Have Now
The $97 billion asset Silicon Valley Bank (NASDAQ: SIVB) has managed to pull off a feat that few bank stocks have managed to achieve during the coronavirus pandemic: It saw its stock soar to an
3 Tricks for a More Relaxing Retirement
Retirement is supposed to be your reward for decades of hard work, the time you can finally kick back and set your own schedule. The trouble is, retirement can bring a new set of stressors into your
Netflix in 3 Charts
Netflix (NASDAQ: NFLX) has been an incredible stock, rising roughly 20-fold over the past decade. Its current market capitalization of $214 billion makes it one of the most valuable companies in the
3 Recent IPOs to Add to Your Watchlist
There have been many interesting IPOs in 2020. Even if you generally avoid new offerings, there are a few of this year's debutantes that should be on your watchlist. Don't dismiss the rookie class
3 Long-Shot Coronavirus Vaccine Stocks to Watch in December
Even for people who like to bet on the underdog, it doesn't make much sense to place a bet after the race is over. Now that Moderna and Pfizer have both announced that their coronavirus vaccine
Home Prices Are Up Over 15%. Here's Why.
Image source: Getty Images.
While it doesn't influence our opinions of products, we do receive compensation from partners whose offers appear here. We're on your side, always. See our full
Why Electronic Arts Is Sending $3 Billion to Investors
Investors can be hard to please sometimes. Electronic Arts' (NASDAQ: EA) stock fell after the company announced record metrics for its fiscal second quarter thanks to a flood of hit content releases
Better Cannabis Stock: Aurora Cannabis or Canopy Growth?
In the face of financial and funding hurdles as well as state and federal discrepancies in the law, U.S. cannabis companies have done exceptionally well this year, driven by a surge in cannabis


